He Wei, Zheng Zhijin, Zhao Qian, Zhang Renxia, Zheng Hui
Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, Jiangsu, China.
MOE Key Laboratory of Geriatric Disease and Immunology of Ministry of Education of China, Collaborative Innovation Center of Hematology, International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences (IBMS), School of Medicine, Soochow University, Suzhou 215123, Jiangsu, China.
Pathogens. 2024 Dec 13;13(12):1100. doi: 10.3390/pathogens13121100.
Chronic hepatitis B (CHB) caused by HBV infection has brought suffering to numerous people. Due to the stable existence of HBV cccDNA, the original template for HBV replication, chronic hepatitis B (CHB) is difficult to cure completely. Despite current antiviral strategies being able to effectively limit the progression of CHB, complete CHB cure requires directly targeting HBV cccDNA. In this review, we discuss strategies that may achieve a complete cure of CHB, including inhibition of cccDNA de novo synthesis, targeting cccDNA degradation through host factors and small molecules, CRISP-Cas9-based cccDNA editing, and silencing cccDNA epigenetically.
由乙肝病毒(HBV)感染引起的慢性乙型肝炎(CHB)给众多人带来了痛苦。由于HBV共价闭合环状DNA(cccDNA)这一HBV复制的原始模板稳定存在,慢性乙型肝炎(CHB)难以被完全治愈。尽管目前的抗病毒策略能够有效限制CHB的进展,但彻底治愈CHB需要直接靶向HBV cccDNA。在这篇综述中,我们讨论了可能实现CHB彻底治愈的策略,包括抑制cccDNA的从头合成、通过宿主因子和小分子靶向cccDNA降解、基于CRISP-Cas9的cccDNA编辑以及对cccDNA进行表观遗传沉默。